Cargando…
Parkinson’s Disease-Associated Mutant LRRK2-Mediated Inhibition of miRNA Activity is Antagonized by TRIM32
Parkinson’s disease (PD) is the second most common neurodegenerative disorder. Accumulating evidences suggest that PD might have a strong neurodevelopmental component. Among the genetic cases, mutations in the leucine-rich repeat kinase 2 (LRRK2) are well known to be disease causing. Although the mo...
Autores principales: | Gonzalez-Cano, Laura, Menzl, Ingeborg, Tisserand, Johan, Nicklas, Sarah, Schwamborn, Jens C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842508/ https://www.ncbi.nlm.nih.gov/pubmed/28508149 http://dx.doi.org/10.1007/s12035-017-0570-y |
Ejemplares similares
-
Regulatory feedback loop between TP73 and TRIM32
por: Gonzalez-Cano, L, et al.
Publicado: (2013) -
TRIM32 Regulates Skeletal Muscle Stem Cell Differentiation and Is Necessary for Normal Adult Muscle Regeneration
por: Nicklas, Sarah, et al.
Publicado: (2012) -
TRIM32 modulates pluripotency entry and exit by directly regulating Oct4 stability
por: Bahnassawy, Lamia’a, et al.
Publicado: (2015) -
The RNA helicase DDX6 regulates cell-fate specification in neural stem cells via miRNAs
por: Nicklas, Sarah, et al.
Publicado: (2015) -
Is serine racemase (SRR) a second hit target for LRRK2-G2019S induced Parkinson’s disease?
por: Nickels, Sarah Louise, et al.
Publicado: (2020)